Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

SERT

  • Preserved Serotonin Transporter Availability in Parkinson Disease Measured with Either [<sup>11</sup>C]MADAM or [<sup>11</sup>C]DASB: A Study Including 2 Separate Cohorts of Nondepressed Patients
    You have access
    Preserved Serotonin Transporter Availability in Parkinson Disease Measured with Either [11C]MADAM or [11C]DASB: A Study Including 2 Separate Cohorts of Nondepressed Patients
    Minyoung Oh, Joachim Brumberg, Vesna Sossi and Andrea Varrone
    Journal of Nuclear Medicine February 1, 2025, 66 (2) 309-314; DOI: https://doi.org/10.2967/jnumed.124.268233
  • You have access
    Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases
    Merijn Joling, Chris Vriend, Odile A. van den Heuvel, Pieter G.H.M. Raijmakers, Paul A. Jones, Henk W. Berendse and Jan Booij
    Journal of Nuclear Medicine July 1, 2017, 58 (7) 1117-1123; DOI: https://doi.org/10.2967/jnumed.116.182139
  • You have access
    In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice
    Michael Walker, Walter Ehrlichmann, Anke Stahlschmidt, Bernd J. Pichler and Kristina Fischer
    Journal of Nuclear Medicine January 1, 2016, 57 (1) 115-121; DOI: https://doi.org/10.2967/jnumed.115.163683
SNMMI

© 2025 SNMMI

Powered by HighWire